Theragene Pharmaceuticals Company

Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.


Investors

Headquarters: San Diego, California, United States
Last Funding Type: Convertible Note
Investors Number: 1
Last Funding Date: 2017
Employee Number: 1-10
Total Funding: 548000
Founded Date: 2011
Technology: Cancer
Estimated Revenue: $1M to $10M
Investor Type: Early Stage Venture
Industry: Biotechnology, Pharmaceutical, Therapeutics
Funding Status: Early Stage Venture